In this episode, Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS, explores key considerations for transgender people with HIV (PWH).Listen as she gives perspectives on:Department of Health and Human Services (DHHS) guideline recommendations for transgender PWHProviding HIV care within a gender-affirmative care model, including discussion of strategies, barriers, and facilitatorsGender-affirmative hormone therapy optionsDrug–drug interaction potential between gender-affirmative hormone therapy and antiretroviral therapyRecommended laboratory monitoring while receiving gender-affirming hormone therapyThe cascade of care for transgender PWH and barriers to engagement and retention in carePresenter:Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVSAssistant Professor of PediatricsDivision of Pediatric Infectious DiseasesPediatric and Adolescent HIV Children’s Hospital at MontefiorePediatric Hospital of Albert Einstein College of MedicineBronx, New York Follow along with the slides at:https://bit.ly/3wOdKVoLink to full program:https://bit.ly/3fOl0XX Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related